|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | |
| C07D 401/14 | |||
| C07D 407/14 | |||
| C07D 413/14 | |||
| C07D 471/04 | |||
| C07D 491/048 | |||
| A61K 31/437 | |||
| A61K 31/4439 | |||
| A61K 31/444 | |||
| A61K 31/497 | |||
| A61K 31/506 | |||
| A61P 9/00 | |||
| A61P 25/28 | |||
| A61P 29/00 | |||
| A61P 37/00 | |||
| A61K 31/585 | |||
| A61K 31/5377 | |||
| A61K 31/496 | |||
| A61K 31/4709 | |||
| A61K 45/06 |
| (11) | Number of the document | 3363797 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17208659.7 |
| Date of filing the European patent application | 2010-07-12 | |
| (97) | Date of publication of the European application | 2018-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 225076 P | 2009-07-13 | US | |
| 225079 P | 2009-07-13 | US | |
| 289263 P | 2009-12-22 | US |
| (72) |
CORKEY, Britton, US
GRAUPE, Michael, US
KOCH, Keith, US
MELVIN, Lawrence S., US
NOTTE, Gregory, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ORAL DOSAGE FORM OF APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS |
| ORAL DOSAGE FORM OF APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS |